Effectiveness of a Physical Therapy Telerehabilitation Program in Long Post COVID-19 Symptoms in Primary Health Care.

NCT05121688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2024-08-22

No results posted yet for this study

Summary

The evolution of Coronavirus disease 2019 (COVID-19) pandemic makes it more necessary the intervention of Primary Health Care Physiotherapy Units in patients with respiratory and/or functional sequelae after suffering from SARS-CoV-2 (acute respiratory sindrome by coronavirus) virus infection.

Since some months ago, Primary Health Care use telerehabilitation tools to connect patients and health care professions while maintaining social distancing and restrictions. Tele-physiotherapy is a field of physiotherapy which has the advantage of providing physical therapy interventions to patients' complications after COVID-19 by using a videoconferencing method. The aim of this study is to evaluate the effectiveness of a multimodal Physical Therapy telerehabilitation program in persistent post COVID-19 symptoms in Primary Health Care.

Conditions

  • COVID-19
  • Physical Therapy Modalities
  • Telerehabilitation
  • Primary Health Care

Interventions

OTHER

Physiotherapy

A Tele-face-to-face multimodal physical therapy program based on health education, respiratory exercises, physical training exercises, aerobic exercises and functional mobility.

Sponsors & Collaborators

  • Spanish Primary Health Care

    collaborator UNKNOWN
  • Universidad Complutense de Madrid

    lead OTHER

Principal Investigators

  • María José Díaz-Arribas, PhD. · Director of Physical Therapy Section.

  • Gustavo Plaza Manzano, PhD. · Sub-director of Pysical Therapy Section.

  • Mabel Ramos Sánchez, PhD. · Tenured University Professor.

  • José Calvo Paniagua, Master · Associated Clinical Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-25
Primary Completion
2022-05-15
Completion
2023-05-09

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05121688 on ClinicalTrials.gov